| Literature DB >> 31538926 |
Anne Pohlmann, Donata Hoffmann, Christian Grund, Susanne Koethe, Daniela Hüssy, Simone M Meier, Jacqueline King, Jan Schinköthe, Reiner Ulrich, Timm Harder, Martin Beer.
Abstract
We genetically characterized highly pathogenic avian influenza virus A(H5N6) clade 2.3.4.4b isolates found in Germany in 2017-2018 and assessed pathogenicity of representative H5N5 and H5N6 viruses in ferrets. These viruses had low pathogenicity; however, continued characterization of related isolates is warranted because of their high potential for reassortment.Entities:
Keywords: Germany; H5N5; H5N6; H5N8; H5Nx; HPAI; clade 2.3.4.4b; epizootic; ferret model; highly pathogenic avian influenza; influenza; reassortment; respiratory infections; viruses; zoonoses; zoonotic potential
Year: 2019 PMID: 31538926 PMCID: PMC6759249 DOI: 10.3201/eid2510.181931
Source DB: PubMed Journal: Emerg Infect Dis ISSN: 1080-6040 Impact factor: 6.883
FigurePhylogenetic clustering and geographic distribution of highly pathogenic avian influenza A(H5N6) viruses, Europe, 2017–2018. A) Supernetwork generated by using maximum-likelihood trees of influenza virus full genomes with RAxML (https://cme.h-its.org/exelixis/web/software/raxml/index.html) and 1,000 bootstrap iterations followed by network analysis with SplitsTree4 (http://ab.inf.uni-tuebingen.de/software/splitstree4). Reassortant viruses are grouped according to their phylogenetic results. Scale bar indicates nucleotide substitutions per site. The mosaic genome structure of reassortant groups I and II is also provided. Gene segment descriptions are given in Appendix Figure). B) Geographic locations of cluster isolates. Inset of cluster in the Netherlands is provided for easier visualization. L, Luxembourg.
Viral RNA loads in nasal washing samples from ferrets infected with highly pathogenic avian influenza A(H5N6/H5N5) clade 2.3.4.4b virus isolates from Germany, 2017–2018, and seroconversion in study assessing virus zoonotic risk*
| Group | Day postinfection, viral RNA load, genome copies/µL | Seroconversion† | |||||
|---|---|---|---|---|---|---|---|
| 0 | 1 | 3 | 5 | 7 | 9 | ||
| Controls | – | – | – | – | – | – | – |
| H5N5 | – | 0.2 | 0.2 | 0.1 | 100.6 | ND‡ | +/−§ |
| – | 1.2 | 2.8 | 0.1 | – | – | + | |
| – | 1.9 | 0.9 | 2.9 | – | – | + | |
| – | 1.2 | – | 0.1 | – | – | + | |
| – | 0.1 | – | 8.2 | 0.9 | – | + | |
| H5N6 | – | – | 0.8 | 1.3 | 1.3 | – | + |
| – | 0.2 | 1.9 | 13.8 | 3.2 | – | + | |
| – | 0.2 | – | 0.2 | 0.2 | – | + | |
| – | – | – | – | – | – | + | |
| – | 0 | 1.3 | 0.2 | 4.2 | – | + | |
*ND, not done; –, negative. †Seroconversion measured with sensitive nucleoprotein ELISA (ID Screen Influenza A Antibody Competition ELISA Kit; ID.Vet, https://www.id-vet.com) with day 14 or 7 serum sample, depending on day of animal sacrifice, and compared with preinoculation serum sample. ‡Sacrificed day 7 because animal displayed neurologic symptoms. §Reaction interpreted as reactive but not positive.